{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:10:13Z","timestamp":1792671013326,"version":"4.5.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.autrev.2023.103338","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T11:28:21Z","timestamp":1681471701000},"page":"103338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Hypertrophic pachymeningitis in ANCA-associated vasculitis: Clinical and immunopathological features and insights"],"prefix":"10.1016","volume":"22","author":[{"given":"Yasuhiro","family":"Shimojima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2023.103338_bb0005","article-title":"Deux cas d\u2019atrophie musculaire progressive avec lesions de la substance grice et des faisceaux anterolateraux de la moelle epiniere","volume":"2","author":"Charcot","year":"1869","journal-title":"Arch Physiol Norm Pathol"},{"key":"10.1016\/j.autrev.2023.103338_bb0010","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/jnnp.38.12.1170","article-title":"Hypertrophic granulomatous cranial pachymeningitis causing progressive blindness in a chronic dialysis patient","volume":"38","author":"Feringa","year":"1975","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2023.103338_bb0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jcp.16.2.137","article-title":"Extensive intracranial lesions in a case of orbital non-specific granuloma combined with polyarteritis nodosa","volume":"16","author":"Astrom","year":"1963","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2023.103338_bb0020","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/jnnp-2013-306410","article-title":"A nationwide survey of hypertrophic pachymeningitis in Japan","volume":"85","author":"Yonekawa","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2023.103338_bb0025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/brain\/awt314","article-title":"Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody","volume":"137","author":"Yokoseki","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2023.103338_bb0030","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s10067-020-04971-2","article-title":"Cerebrospinal fluid biomarkers implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis","volume":"39","author":"Ikeda","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0035","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1212\/01.WNL.0000113748.53023.B7","article-title":"Idiopathic hypertrophic pachymeningitis","volume":"62","author":"Kupersmith","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103338_bb0040","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jocn.2013.09.025","article-title":"Idiopathic hypertrophic pachymeningitis: clinical, laboratory and neuroradiologic features in China","volume":"21","author":"Zhao","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.autrev.2023.103338_bb0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jns.2016.06.024","article-title":"Hypertrophic pachymeningitis","volume":"367","author":"Hahn","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2023.103338_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jns.2014.08.033","article-title":"Arachnoid involved in idiopathic hypertrophic pachymeningitis","volume":"346","author":"Zhao","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2023.103338_bb0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1440-1789.2003.00520.x","article-title":"Idiopathic hypertrophic pachymeningitis","volume":"23","author":"Riku","year":"2003","journal-title":"Neuropathology"},{"key":"10.1016\/j.autrev.2023.103338_bb0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1440-1789.2000.00282.x","article-title":"P-ANCA-positive Wegener\u2019s granulomatosis presenting with hypertrophic pachymeningitis and multiple cranial neuropathies: case report and review of literature","volume":"20","author":"Nagashima","year":"2000","journal-title":"Neuropathology"},{"key":"10.1016\/j.autrev.2023.103338_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5387\/fms.59.56","article-title":"Hypertrophic cranial pachymeningitis in MPO-ANCA-related vasculitis: a case report and literature review","volume":"59","author":"Watanabe","year":"2013","journal-title":"Fukushima J Med Sci"},{"key":"10.1016\/j.autrev.2023.103338_bb0070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/1756-185X.13046","article-title":"Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: a retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"20","author":"Shimojima","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103338_bb0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/03009742.2018.1498916","article-title":"Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patients","volume":"48","author":"Sakairi","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0080","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00415-017-8416-0","article-title":"Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis","volume":"264","author":"Choi","year":"2017","journal-title":"J Neurol"},{"issue":"Suppl. 124","key":"10.1016\/j.autrev.2023.103338_bb0085","first-page":"176","article-title":"Efficacy of rituximab for anti-neutrophil cytoplasmic antibody-associated hypertrophic pachymeningitis: a case series","volume":"38","author":"Kobayashi","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.565088","article-title":"Hypertrophic Pachymeningitis in a southern Chinese population: a retrospective study","volume":"11","author":"Xiao","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2023.103338_bb0095","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10067-018-4372-z","article-title":"Incidence and risk factors of new-onset hypertrophic pachymeningitis in patients with anti-neutrophil antibody-associated vasculitis: using logistic regression and classification tree analysis","volume":"38","author":"Imafuku","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.anl.2022.01.009","article-title":"Imaging characteristics of hypertrophic pachymeningitis due to ANCA-associated vasculitis","volume":"49","author":"Takagi","year":"2022","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.autrev.2023.103338_bb0105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10072-018-3619-4","article-title":"The clinical and imaging features of hypertrophic pachymeningitis: a clinical analysis on 22 patients","volume":"40","author":"Chen","year":"2019","journal-title":"Neurol Sci"},{"key":"10.1016\/j.autrev.2023.103338_bb0110","doi-asserted-by":"crossref","first-page":"2926419","DOI":"10.1155\/2020\/2926419","article-title":"Hypertrophic Pachymeningitis in Chinese patients: presentation, radiological findings, and clinical course","volume":"2020","author":"Bi","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2023.103338_bb0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/14397595.2016.1177926","article-title":"Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): a retrospective analysis of 235 patients from a nationwide survey in Japan","volume":"27","author":"Harabuchi","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0120","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2332\/allergolint.14-RAI-0774","article-title":"Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis","volume":"63","author":"Yoshida","year":"2014","journal-title":"Allergol Int"},{"key":"10.1016\/j.autrev.2023.103338_bb0125","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10067-016-3520-6","article-title":"Pachymeningitis in granulomatosis with polyangiitis: case series with earlier onset in younger patients and literature review","volume":"36","author":"Higuera-Ortiz","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0130","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011413","article-title":"Characteristics, outcome and treatments with cranial pachymeningitis: a multicenter French retrospective study of 60 patients","volume":"97","author":"Mekinian","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103338_bb0135","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103338_bb0140","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3389\/fneur.2018.01166","article-title":"Central nervous system involvement in ANCA-associated Vasculitis: what neurologists need to know","volume":"9","author":"Zheng","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2023.103338_bb0145","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13075-022-02898-4","article-title":"Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS)","volume":"24","author":"Shimojima","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103338_bb0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ana.410330103","article-title":"Neurological involvement in Wegener\u2019s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic","volume":"33","author":"Nishino","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2023.103338_bb0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.md.0000200166.90373.41","article-title":"Central nervous system involvement in Wegener granulomatosis","volume":"85","author":"Seror","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103338_bb0160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.rdc.2017.06.006","article-title":"Central nervous system disease in Antineutrophil cytoplasmic antibodies-associated Vasculitis","volume":"43","author":"Graf","year":"2017","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.autrev.2023.103338_bb0165","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/rheumatology\/keu336","article-title":"Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes","volume":"54","author":"De Luna","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2023.103338_bb0170","first-page":"397","article-title":"Pachymeningitis in microscopic polyangiitis (MPA): a case report and a review of central nervous system involvement in MPA","volume":"18","author":"Kono","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0175","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1212\/01.WNL.0000143063.12569.FC","article-title":"Hypertrophic pachymeningitis as an initial and cardinal manifestation of microscopic polyangiitis","volume":"63","author":"Furukawa","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103338_bb0180","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2169\/internalmedicine.47.0505","article-title":"Fatal hemoperitoneum preceded by cranial hypertrophic pachymeningitis in a patient with ANCA-positive microscopic polyangitis","volume":"47","author":"Hayashi","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2023.103338_bb0185","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/jgs.12291","article-title":"Hypertrophic pachymeningitis in an individual with microscopic polyangiitis","volume":"61","author":"Tsuda","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.autrev.2023.103338_bb0190","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.2169\/internalmedicine.8683-16","article-title":"Central diabetes insipidus in refractory Antineutrophil cytoplasmic antibody-associated Vasculitis","volume":"56","author":"Ohashi","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2023.103338_bb0195","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1097\/RHU.0000000000000694","article-title":"Development of hypertrophic Pachymeningitis in a patient with Antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with Polyangiitis","volume":"25","author":"Nakano","year":"2018","journal-title":"J Clin Rheumatol"},{"issue":"Suppl","key":"10.1016\/j.autrev.2023.103338_bb0200","first-page":"S121","article-title":"Churg-Strauss syndrome with pachymeningitis refractory to steroid therapy atone--a case report","volume":"28","author":"Lio","year":"2001","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.autrev.2023.103338_bb0205","first-page":"14","article-title":"Pathological findings of hypertrophic pachymeningitis associated with eosinophilic granulomatosis with polyangiitis","author":"Shiraishi","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2023.103338_bb0210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1620\/tjem.256.241","article-title":"Hypertrophic Pachymeningitis development in eosinophilic granulomatosis with Polyangiitis at relapse of disease: a case-based review","volume":"256","author":"Kiyohara","year":"2022","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.autrev.2023.103338_bb0215","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/197140090702000211","article-title":"\u2018Eiffel-by-Night\u2019: a new MR sign demonstrating reactivation in idiopathic hypertrophic Pachymeningitis","volume":"20","author":"Thomas","year":"2007","journal-title":"Neuroradiol J"},{"key":"10.1016\/j.autrev.2023.103338_bb0220","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1148\/rg.272065155","article-title":"Patterns of contrast enhancement in the brain and meninges","volume":"27","author":"Smirniotopoulos","year":"2007","journal-title":"Radiographics"},{"key":"10.1016\/j.autrev.2023.103338_bb0225","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1007\/s10072-021-05782-2","article-title":"Magnetic resonance imaging findings of intracranial hypotension","volume":"43","author":"Beyhan","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.autrev.2023.103338_bb0230","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/head.13005","article-title":"Granulomatosis with Polyangiitis-associated hypertrophic Pachymeningitis mimicking spontaneous intracranial hypotension: a case report","volume":"57","author":"Jung","year":"2017","journal-title":"Headache"},{"key":"10.1016\/j.autrev.2023.103338_bb0235","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12883-020-01815-z","article-title":"Polycystic subdural hygroma associated with immunoglobulin G4-related intracranial hypertrophic pachymeningitis: a case report","volume":"20","author":"Ota","year":"2020","journal-title":"BMC Neurol"},{"key":"10.1016\/j.autrev.2023.103338_bb0240","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/RLU.0000000000003605","article-title":"FDG PET\/CT in 3 cases of hypertrophic Pachymeningitis associated with Antineutrophil cytoplasmic antibody-associated Vasculitis","volume":"46","author":"Zhang","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.autrev.2023.103338_bb0245","article-title":"Hypertrophic spinal pachymeningitis caused by ANCA-associated vasculitis revealed by 18F-FDG PET\/CT: a case report","volume":"100","author":"Wu","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103338_bb0250","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00296-019-04338-0","article-title":"Pituitary involvement in patients with granulomatosis with polyangiitis: case series and literature review","volume":"39","author":"Gu","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2023.103338_bb0255","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1210\/jc.2014-1962","article-title":"Pituitary dysfunction in granulomatosis with polyangiitis: the Mayo Clinic experience","volume":"99","author":"Kapoor","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2023.103338_bb0260","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000748","article-title":"Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature","volume":"94","author":"De Parisot","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103338_bb0265","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002053","article-title":"ANCA-associated systemic Vasculitis presenting with hypertrophic spinal Pachymeningitis: a report of 2 cases and review of literature","volume":"94","author":"Li","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"483\u20134","key":"10.1016\/j.autrev.2023.103338_bb0270","first-page":"7","article-title":"May 2001: 32 year old female with dural mass encircling cervical spinal cord","volume":"11","author":"McCarthy","year":"2001","journal-title":"Brain Pathol"},{"key":"10.1016\/j.autrev.2023.103338_bb0275","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jbspin.2006.10.008","article-title":"Thoracic spinal cord compression indicating Wegener\u2019s granulomatosis in a patient with a previous presumptive diagnosis of microscopic polyangiitis","volume":"74","author":"Bachmeyer","year":"2007","journal-title":"Joint Bone Spine"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2023.103338_bb0280","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00586-007-0318-x","article-title":"The upper thoracic spinal cord compression as the initial manifestation of Wegener\u2019s granulomatosis: a case report","volume":"16","author":"Wang","year":"2007","journal-title":"Eur Spine J"},{"key":"10.1016\/j.autrev.2023.103338_bb0285","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis activity score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103338_bb0290","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/art.20082","article-title":"Predicting mortality in systemic Wegener\u2019s granulomatosis: a survival analysis based on 93 patients","volume":"51","author":"Bligny","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103338_bb0295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12016-007-8066-6","article-title":"Renal involvement in Wegener\u2019s granulomatosis","volume":"35","author":"Renaudineau","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2023.103338_bb0300","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.rdc.2017.06.011","article-title":"Involvement of the peripheral nervous system in Polyarteritis Nodosa and Antineutrophil cytoplasmic antibodies-associated Vasculitis","volume":"43","author":"Imboden","year":"2017","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.autrev.2023.103338_bb0305","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.anl.2021.01.023","article-title":"The association between ear involvement and clinical features and prognosis in ANCA-associated vasculitis","volume":"48","author":"Hosokawa","year":"2021","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.autrev.2023.103338_bb0310","first-page":"S60","article-title":"Meningeal involvement in Wegener\u2019s granulomatosis is associated with localized disease","volume":"24","author":"Di Comite","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0315","series-title":"Otitis Externa, Otitis Media, and Mastoiditis. Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases","first-page":"767","author":"Klein","year":"2015"},{"key":"10.1016\/j.autrev.2023.103338_bb0320","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.autrev.2016.02.005","article-title":"Granulomatosis with polyangiitis and facial palsy: literature review and insight in the autoimmune pathogenesis","volume":"15","author":"Iannella","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103338_bb0325","first-page":"1603","article-title":"MR imaging findings of spinal dural involvement with Wegener granulomatosis","volume":"23","author":"Albayram","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.autrev.2023.103338_bb0330","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1212\/WNL.51.6.1769","article-title":"Granulomatous compressive thoracic myelopathy as the initial manifestation of Wegener\u2019s granulomatosis","volume":"51","author":"Kelly","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103338_bb0335","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2019.01.010","article-title":"Cerebrospinal fluid cytokine\/chemokine\/growth factor profiles in idiopathic hypertrophic pachymeningitis","volume":"330","author":"Zhang","year":"2019","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2023.103338_bb0340","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into TGF-beta\/Smad signaling in tissue fibrosis","volume":"292","author":"Hu","year":"2018","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.autrev.2023.103338_bb0345","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-beta signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"key":"10.1016\/j.autrev.2023.103338_bb0350","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cyto.2017.08.013","article-title":"Increased BAFF and APRIL levels in the cerebrospinal fluid of patients with anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis","volume":"99","author":"Shimojima","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2023.103338_bb0355","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","article-title":"The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity","volume":"24","author":"Vincent","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.autrev.2023.103338_bb0360","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2006.04.004","article-title":"BAFF, APRIL and human B cell disorders","volume":"18","author":"Tangye","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2023.103338_bb0365","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2023.103338_bb0370","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaut.2005.08.004","article-title":"BAFF is elevated in serum of patients with Wegener\u2019s granulomatosis","volume":"25","author":"Krumbholz","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103338_bb0375","doi-asserted-by":"crossref","first-page":"c339","DOI":"10.1159\/000323393","article-title":"Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity","volume":"118","author":"Nagai","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.autrev.2023.103338_bb0380","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1136\/ard.2011.153890","article-title":"ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process","volume":"70","author":"Holden","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103338_bb0385","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.autrev.2015.06.001","article-title":"Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients","volume":"14","author":"Fitzner","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103338_bb0390","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2023.103338_bb0395","doi-asserted-by":"crossref","DOI":"10.1093\/cei\/uxad024","article-title":"Features of BAFF and APRIL receptors on circulating B cells in antineutrophil cytoplasmic antibody-associated vasculitis","author":"Shimojima","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2023.103338_bb0400","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s10067-020-05270-6","article-title":"Cerebrospinal fluid levels of BAFF and APRIL as direct indicators of disease activity in anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis","volume":"39","author":"Shimojima","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0405","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/WNL.48.1.263","article-title":"Meningeal involvement in Wegener\u2019s granulomatosis confirmed and monitored by positive circulating antineutrophil cytoplasm in cerebrospinal fluid","volume":"48","author":"Spranger","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103338_bb0410","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/ndt\/15.6.893","article-title":"Vasculitic wallenberg syndrome with detection of anti-proteinase 3 antibodies in the cerebrospinal fluid of a patient with severe Wegener\u2019s granulomatosis and only mild kidney involvement","volume":"15","author":"Faust","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2023.103338_bb0415","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/0972-2327.93284","article-title":"Hypertrophic pachymeningitis in a patient with Takayasu arteritis: one more association?","volume":"15","author":"Wattamwar","year":"2012","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.autrev.2023.103338_bb0420","first-page":"11","article-title":"Spinal hypertrophic Pachymeningitis causing thoracic myelopathy in a patient of Takayasu arteritis: a case report","author":"Murugan","year":"2021","journal-title":"JBJS case Connect"},{"key":"10.1016\/j.autrev.2023.103338_bb0425","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2169\/internalmedicine.55.5340","article-title":"Hypertrophic Pachymeningitis as a potential cause of headache associated with temporal arteritis","volume":"55","author":"Tokushige","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2023.103338_bb0430","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1056\/NEJMcpc0805313","article-title":"Case records of the Massachusetts General Hospital. Case 36-2008. A 59-year-old man with chronic daily headache","volume":"359","author":"Brass","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2023.103338_bb0435","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1526-4610.2004.4200_2.x","article-title":"Focal hypertrophic pachymeningitis in association with temporal arteritis","volume":"44","author":"Kuhn","year":"2004","journal-title":"Headache"},{"key":"10.1016\/j.autrev.2023.103338_bb0440","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00415-003-0914-6","article-title":"Focal hypertrophic cranial pachymeningitis associated with temporal arteritis: a new case report","volume":"250","author":"Marano","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2023.103338_bb0445","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/art.41527","article-title":"Temporal arteritis revealing Antineutrophil cytoplasmic antibody-associated Vasculitides: a case-control study","volume":"73","author":"Delaval","year":"2021","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103338_bb0450","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10067-013-2457-2","article-title":"Successful treatment of refractory aortitis in antineutrophil cytoplasmic antibody-associated vasculitis using tocilizumab","volume":"33","author":"Takenaka","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0455","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10067-021-05971-6","article-title":"Hypertrophic pachymeningitis in polyarteritis nodosa: a case-based review","volume":"41","author":"Nomura","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0460","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00296-005-0615-9","article-title":"Acute pachymeningitis mimicking subdural hematoma in a patient with polyarteritis nodosa","volume":"25","author":"Song","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2023.103338_bb0465","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2796.2006.01676.x","article-title":"Intravenous immunoglobulin-associated cranial pachymeningitis","volume":"260","author":"Marie","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2023.103338_bb0470","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/14397595.2017.1290911","article-title":"Current approach to the diagnosis of IgG4-related disease - combination of comprehensive diagnostic and organ-specific criteria","volume":"27","author":"Umehara","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0475","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2023.103338_bb0480","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12026-016-8863-1","article-title":"Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease","volume":"65","author":"De Virgilio","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2023.103338_bb0485","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e31829cce35","article-title":"IgG4-related disease and hypertrophic pachymeningitis","volume":"92","author":"Wallace","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103338_bb0490","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European league against rheumatism classification criteria for IgG4-related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103338_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.986694","article-title":"IgG4-related hypertrophic pachymeningitis with ANCA-positivity: a case series report and literature review","volume":"13","author":"Xia","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2023.103338_bb0500","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.2169\/internalmedicine.8550-21","article-title":"Hypertrophic Pachymeningitis with characteristics of both IgG4-related disorders and granulomatosis with Polyangiitis","volume":"61","author":"Mori","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2023.103338_bb0505","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12026-019-9070-7","article-title":"Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature","volume":"67","author":"Kawashima","year":"2019","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2023.103338_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103285","article-title":"Pachymeningitis associated with IgG4-related disease and ANCA positivity: case report and review of the literature","volume":"22","author":"Gautier","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103338_bb0515","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/ar758","article-title":"Autoantibodies in vasculitis","volume":"5","author":"Wiik","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103338_bb0520","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1111\/ene.14904","article-title":"Rheumatoid meningitis: a systematic review and meta-analysis","volume":"28","author":"Villa","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2023.103338_bb0525","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1177\/0961203319862867","article-title":"SLE pachymeningitis and multiple cranial nerve palsies: a case report and review of the literature","volume":"28","author":"John","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2023.103338_bb0530","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004737","article-title":"Cranial and lumbosacral hypertrophic pachymeningitis associated with systemic lupus erythematosus: a case report","volume":"95","author":"Han","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103338_bb0535","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2169\/internalmedicine.9406-17","article-title":"Hypertrophic Pachymeningitis in Sj\u00f6gren\u2019s syndrome","volume":"57","author":"Nakano","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2023.103338_bb0540","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10072-018-3637-2","article-title":"Case report: hypertrophic pachymeningitis associated with Sj\u00f6gren\u2019s syndrome","volume":"40","author":"Heo","year":"2019","journal-title":"Neurol Sci"},{"key":"10.1016\/j.autrev.2023.103338_bb0545","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1111\/j.1756-185X.2012.01750.x","article-title":"Hypertrophic pachymeningitis in systemic sclerosis sine scleroderma","volume":"15","author":"Kumar","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103338_bb0550","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2169\/internalmedicine.32.510","article-title":"Hypertrophic cranial pachymeningitis associated with mixed connective tissue disease; a comparison with idiopathic and infectious pachymeningitis","volume":"32","author":"Fujimoto","year":"1993","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2023.103338_bb0555","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5607\/en.2015.24.3.252","article-title":"Neuro-Beh\u00e7et\u2019s disease presenting as hypertrophic Pachymeningitis","volume":"24","author":"Yoon","year":"2015","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.autrev.2023.103338_bb0560","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jns.2014.12.020","article-title":"A case of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome presenting with hypertrophic pachymeningitis","volume":"349","author":"Shiraishi","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2023.103338_bb0565","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jocn.2010.04.019","article-title":"Hypertrophic pachymeningitis and cerebral venous sinus thrombosis in inflammatory bowel disease","volume":"17","author":"Xia","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.autrev.2023.103338_bb0570","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/01658107.2016.1212079","article-title":"A rare case of unilateral progressive vision loss and Pachymeningitis","volume":"40","author":"Valenzuela","year":"2016","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.autrev.2023.103338_bb0575","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00415-019-09233-z","article-title":"Frequent central nervous system, pachymeningeal and plexus MRI changes in POEMS syndrome","volume":"266","author":"Ziff","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2023.103338_bb0580","first-page":"9","article-title":"Pachymeningitis in biopsy-proven sarcoidosis: clinical course, radiographic findings, response to treatment, and long-term outcomes","author":"Chakales","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2023.103338_bb0585","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/ard.59.12.1001a","article-title":"A case of rheumatoid meningitis positive for perinuclear antineutrophil cytoplasmic antibody","volume":"59","author":"Funauchi","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103338_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109843","article-title":"Neutrophil extracellular trap: a key player in the pathogenesis of autoimmune diseases","volume":"116","author":"Sadeghi","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2023.103338_bb0595","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000450850","article-title":"Hypertrophic Pachymeningitis as an early manifestation of relapsing Polychondritis: case report and review of the literature","volume":"8","author":"Ushiyama","year":"2016","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.autrev.2023.103338_bb0600","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3899\/jrheum.101238","article-title":"Combination of hypertrophic pachymeningitis, PR3-ANCA-positive vasculitis, and relapsing polychondritis","volume":"38","author":"Ca\u00f1as","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0605","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ncn3.130","article-title":"Hypertrophic pachymeningitis and encephalitis in a patient with relapsing polychondritis","volume":"3","author":"Nakamura","year":"2015","journal-title":"Neurol Clin Neurosci"},{"key":"10.1016\/j.autrev.2023.103338_bb0610","first-page":"1","article-title":"Focal Pachymeningitis induced Papilloedema as an early manifestation of relapsing Polychondritis","author":"Rachdi","year":"2022","journal-title":"Neuro-Ophthalmology"},{"key":"10.1016\/j.autrev.2023.103338_bb0615","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s10067-013-2328-x","article-title":"Relapsing polychondritis: a review","volume":"32","author":"Sharma","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103338_bb0620","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11926-015-0549-5","article-title":"Relapsing Polychondritis: an update on pathogenesis, clinical features, diagnostic tools, and therapeutic perspectives","volume":"18","author":"Vitale","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2023.103338_bb0625","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/ard.52.5.384-b","article-title":"Antineutrophil cytoplasmic antibodies in polychondritis","volume":"52","author":"Papo","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103338_bb0630","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103338_bb0635","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","article-title":"BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis","volume":"53","author":"Ntatsaki","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2023.103338_bb0640","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1001\/jama.2021.6615","article-title":"Effect of reduced-dose vs high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated Vasculitis: a randomized clinical trial","volume":"325","author":"Furuta","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.autrev.2023.103338_bb0645","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/annrheumdis-2017-212768","article-title":"Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides","volume":"77","author":"Terrier","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103338_bb0650","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2169\/internalmedicine.46.6156","article-title":"Two cases of refractory Wegener\u2019s granulomatosis successfully treated with rituximab","volume":"46","author":"Tamura","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2023.103338_bb0655","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024028","article-title":"Granulomatosis with polyangiitis with obstructive pneumonia progressing to hypertrophic pachymeningitis: a case report","volume":"100","author":"Hayashi","year":"2021","journal-title":"Medicine (Baltimore)"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:28:01Z","timestamp":1761600481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":131,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1568997223000721"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103338","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertrophic pachymeningitis in ANCA-associated vasculitis: Clinical and immunopathological features and insights","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103338"}}